Joseph Leslie Duffy

USPTO Granted Patents = 15 (Patent Applications = 8)

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 46(Granted Patents)

Company Filing History:

9 out of 2,405

Merck Sharp + Dohme Corp.

Years Active: 2003-2018

Loading Chart...

15 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10143681 - Factor XIa inhibitors (2018-12-04),

2. 10093683 - Factor XIa inhibitors (2018-10-09),

3. 9926285 - Allosteric modulators of nicotinic acetylcholine receptors (2018-03-27),

4. 9840481 - Allosteric modulators of nicotinic acetylcholine receptors (2017-12-12),

5. 8742110 - Spiroxazolidinone compounds (2014-06-03),

6. 8304434 - Substituted aryl sulfone derivatives as calcium channel blockers (2012-11-06),

7. 8273749 - N-substituted oxindoline derivatives as calcium channel blockers (2012-09-25),

8. 7759352 - Substituted imidazole-4-carboxamides as cholecystokinin-1 receptor modulators (2010-07-20),

9. 7671073 - Cyclohexylalanine derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes (2010-03-02),

10. 7388019 - 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes (2008-06-17),

11. 7309714 - Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes (2007-12-18),

12. 7307164 - β-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes (2007-12-11),

13. 7273876 - Substituted bicylic thiophene derivatives, compositions containing such compounds and methods of use (2007-09-25),

14. 7196106 - Cyanothiophene derivatives, compositions containing such compounds and methods of use (2007-03-27),

15. 6642237 - Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides and uses thereof (2003-11-04),

Title: Joseph Leslie Duffy: A Pioneer in Invention

Introduction:

Joseph Leslie Duffy, a passionate inventor based in Cranford, NJ, is a true pioneer in the field of innovation with a dedication to pushing the boundaries of what is possible. His impact and legacy in the world of invention are undeniable, with a track record of 15 patents to his name.

Latest Patents:

One of Joseph Leslie Duffy's latest patents includes "Factor XIa inhibitors," which provides compounds and pharmaceutical compositions for treating thromboses, embolisms, hypercoagulability, or fibrotic changes. These compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.

Career Highlights:

Having worked at companies like Merck Sharp & Dohme Corporation and Merck & Company, Inc., Joseph Leslie Duffy has honed his skills and expertise in the pharmaceutical industry. His innovative spirit and relentless pursuit of solutions have led to the development of groundbreaking inventions.

Collaborations:

Throughout his career, Joseph Leslie Duffy has collaborated with esteemed professionals in the field. Some of his notable coworkers include Ann E Weber and Robert J Mathvink, who have contributed to the success of his inventions and patents.

Conclusion:

In conclusion, Joseph Leslie Duffy's passion for innovation and his commitment to pushing boundaries in the field of invention make him a true pioneer. His contributions to the pharmaceutical industry through his patents and collaborations will undoubtedly leave a lasting impact for years to come.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

8 patents pending:

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.